Dr. Peter J. Carr

Dr. Peter J. Carr is an internationally recognised clinician, researcher, and educator specialising in vascular access and infusion therapy at the University of Galway. As an Associate Professor in the School of Nursing and Midwifery he is Principal Investigator for the Vascular Access and Infusion Therapy Research Group. Within this research group Dr. Carr leads a multidisciplinary team advancing digital technologies, clinical trials, evaluating next-generation vascular access devices and infusion therapy technology to improve patient outcomes across cancer, critical care, and general medicine. He supervises three PhD students investigating vascular access and related interventions for safer delivery of systemic anti-cancer treatment. A passionate educator, Dr. Carr is Director for a postgraduate emergency care programme, three micro credentials in vascular access and a mentor on the Bioinnovate programme.

Dr. Carr’s expertise is widely acknowledged through various leadership roles, including serving as Ireland’s representative on the Global Vascular Access Network (GloVANet)-World Congress on Vascular Access (WoCoVA) global committee and European lead for the Alliance for Vascular Access Teaching & Research (AVATAR) group- where he completed his PhD with the world’s most cited vascular access researchers. He has contributed to pivotal international guidelines and initiatives, such as the ERPIUP consensus guideline on peripheral venous access, and is the lead author of a Cochrane review on vascular access specialist teams.

His research, is cited in numerous clinical guidelines, and is helping shape global best practices for vascular access device selection, insertion, and maintenance for infusion therapy. His research team have represented cancer nursing science at European symposia on Safer Cancer Care and Organisation for European Cancer Institutes.

More recently he is the senior author on work led by PhD scholar and ANP in Cancer Caitríona Duggan Promoting a research agenda for cancer treatment for intravenous devices with clinicians in Europe; the PRACTICE survey.

You can follow him on LinkedIn and X @pcarriv